IFN-γ and T cells are both required for the development of experimental cerebral malaria during P. berghei ANKA infection. Surprisingly, however, the role of IFN-γ in shaping the effector CD4 + and CD8 + T cell response during this infection has not been examined in detail. To address this, we have compared the effector T cell responses in wild-type and IFN-γ −/− mice during P. berghei ANKA infection. The expansion of splenic CD4 + and CD8 + T cells during P. berghei ANKA infection was unaffected by the absence of IFN-γ but the contraction phase of the T cell response was significantly attenuated. Splenic T cell activation and effector function were essentially normal in IFN-γ −/− mice, however, the migration to, and accumulation of, effector CD4 + and CD8 + T cells in the lung, liver and brain was altered in IFN-γ−/− mice. Interestingly, activation and accumulation of T cells in various non-lymphoid organs was differently affected by lack of IFN-γ, suggesting that IFN-γ influences T cell effector function to varying levels in different anatomical locations. Importantly, control of splenic T cell numbers during P. berghei ANKA infection depended upon active IFN-γ-dependent environmental signals -leading to T cell apoptosis -rather than upon intrinsic alterations in T cell programming. This is the first study to fully investigate the role of IFN-γ in modulating T cell function during P. berghei ANKA infection and reveals that IFN-γ is required for efficient contraction of the pool of activated T cells.
Introduction
Plasmodium berghei ANKA infection in susceptible strains of mice leads to the development of experimental cerebral malaria (ECM), a neuropathy that shares many similarities with human cerebral malaria (reviewed 1, 2). The pathogenesis of the terminal stages of ECM is still poorly defined, but it is clear that the prototypic type-1 cytokine IFN-γ plays a pivotal role in the development of cerebral pathology (3) (4) (5) . Thus, IFN-γ-deficient (IFN-γ −/− ) and IFN-γ receptor (IFN-γR)-deficient (IFN-γR −/− ) mice on susceptible backgrounds, including C57BL/6, fail to develop ECM (3, 4) . Notably, high levels of circulating IFN-γ and upregulation of IFN-responsive genes are also correlated with development of cerebral malaria (CM) in humans (reviewed in 6).
It is currently unclear if the resistance of IFN-γR −/− mice to ECM is primarily due to alterations in innate cell or T cell activity, or a combination of both. Both macrophage accumulation within the brain and macrophage function (TNF secretion) are reduced in P. berghei ANKA-infected IFN-γR −/− mice compared to infected wild-type mice (3), suggesting that IFN-γ-responsive macrophages may contribute to the aetiology of ECM. On the other hand, IFN-γ regulates the expression of CCR2, CXCR3, ICAM-1, VCAM-1 and LFA-1 (3, 7) and the production of CCL5 (RANTES), CXCL10 (IP-10), MIG (CXCL9) in the brain during P. berghei ANKA infection (4, 7) suggesting that IFN-γ may contribute to ECM by directing the recruitment of T cells to the brain. In support of this hypothesis, CD8 + T cells, primed in the spleen during P. berghei ANKA infection via cross-presentation of antigen by classical lymphoid dendritic cells (8) (9) (10) , have been shown to migrate to the brain via CXCR3-CXCL10 (IP-10), MIG (CXCL9) and CCR5-CCL5 (RANTES) dependent pathways (4, 7, (11) (12) (13) . T cell migration to the brain is thus reduced in IFN-γ(R) deficient mice (refs) (7) . Since migration of CD8 + T cells to the brain is believed to be a key process in the development of ECM (reviewed 14), through modulating parasite tissue biomass and/ or causing direct endothelial cell damage (15) (16) (17) (18) , these data suggest that alterations in chemokine pathways and resultant attenuated migration of CD8 + T cells is a major reason for the resistance of IFN-γ −/− and IFN-γR −/− mice to ECM.
There is, however, significant evidence from other models that IFN-γ may directly control the activation and expansion of T cells: IFN-γ drives STAT1-dependent expression of T-bet in CD4 + T cells, which is the initial step in the differentiation of Th1 cells (19, 20) . IFN-γR signalling is also required to repress IL-4 production by Th1 cells during recall responses (21) and IFN-γ modulates microglial activation within the brain during experimental autoimmune encephalitis (EAE), controlling both Th1 and Th2 cell activation (22) . Consequently, in the absence of direct IFN-γR signalling, Th1 and CD8 + T cell responses are impaired (23) (24) (25) . Thus, reduced accumulation of T cells in the brains of IFN-γ −/− mice during P. berghei ANKA infection may not be solely due to altered chemotactic signals, but may also be a consequence of impaired T cell activation or differentiation.
In addition to its immunostimulatory effects, IFN-γ may also suppress T cell hyperactivity by limiting CD4 + and CD8 + T cell accumulation or expansion through the induction of apoptosis (26) (27) (28) (29) (30) (31) (32) (33) and by deletion of Ag-presenting dendritic cells (34) . Although few studies have examined in detail the apoptotic pathways regulated by IFN-γ, it has been shown that intrinsic (mitochondrial) and extrinsic (TRAIL, DR5 and TNFR1) pathways of apoptosis are induced in CD4 + T cells by IFN-γ during BCG infection (28) and IFN-γ promotes caspase-8 dependent activation-induced cell death (AICD) of CD4+ T cells in vitro following TCR stimulation (32) . Interestingly, it has been suggested that IFN-γ-dependent apoptosis can occur by paracrine signalling without expression of IFN-γR on T cells (29, 33) , and through autocrine cell-specific IFN-γ signalling (30) . With relevance to malaria infection, Ag-specific (but not non-specific) T cell apoptosis has been described during P. berghei ANKA, P. yoelii and P. chabaudi AS infections (27, 35, 36) . Loss of splenic Ag-specific CD4 + T cells was reduced when cells were adoptively transferred into mice treated with anti-IFN-γ (31), suggesting that IFN-γ was responsible for apoptosis. Importantly, however, the contribution of modified migratory behaviour following treatment with anti-IFN-γ leading to changes in splenic T cell numbers was not addressed. In separate studies, Ag-specific T cell apoptosis has been shown to occur during malaria infection through distinct death receptor-and bax-dependent pathways (37) .
In this study we have compared the T cell response in WT and IFN-γ −/− mice during P. berghei ANKA infection to characterise the alterations in T cell-mediated immune functions that underlie the resistance of IFN-γ −/− mice to ECM. Our results show that IFN-γ is not required for activation of splenic CD4 + and CD8 + T cells during infection but that it is essential for contraction of the splenic effector T cell population through induction of apoptosis. Moreover, we demonstrate that IFN-γ -directs tissue specific migration of CD8 + T cells and CD4 + T cell, but not CD8 + T cell, activation and effector function within peripheral organs. Importantly, we show that persistence of effector T cells in the spleen in IFN-γ −/− mice is due to the absence of active environmental cues during the precise period of ECM development, rather than due to intrinsic differences in T cell programming imprinted during the early stages of infection.
Materials and Methods

Animals and parasites
C57BL/6 (CD45.2 + ), C57BL/6 IFN-γ knock out (IFN-γ −/− ) and C57BL/6 Ly5.1 (CD45.1 + ) mice were bred in-house or purchased from Harlan, Oxford, UK and maintained in individually ventilated cages. Male and female mice were used in separate experiments, and were between 6 and 9 weeks of age. Cryopreserved P. berghei ANKA (Pb ANKA) parasites were thawed and passaged once in vivo in C57BL/6 mice before being used to infect experimental animals. Experimental mice were infected intravenously (i.v.) with 10 4 parasitised red blood cells (pRBC). Parasitaemia was monitored daily by microscopic examination of Giemsa (BDH)-stained thin blood smears. The severity of ECM was determined using a grading system: 1=no signs; 2=ruffled fur/and or abnormal posture; 3=lethargy; 4=reduced responsiveness to stimulation and/or ataxia and/or respiratory distress/hyperventilation; 5= prostration and/or paralysis and/or convulsions. All animals were euthanized when observed at stage 4 or 5.
Tissue processing and flow cytometry
Single cell suspensions of spleen, liver and lung were prepared by homogenising tissues through a 70 μm cell strainer (BD Falcon). Brains were cut into small pieces, aspirated through a 5ml syringe and incubated in HBSS containing 10% FCS with collagenase/dispase (2mg/ml) (Sigma) for 45 mins at room temperature. The brain suspension was then homogenised through a 70μm cell strainer, overlayed on a 30% percoll gradient and centrifuged at 1800g for 10 minutes. The mononuclear cell pellet was collected. Red blood cells were lysed in all samples by the addition of 1% lysing buffer (BD Bioscience). Absolute cell numbers were calculated using a haemocytometer and live/dead cell differentiation was performed using Trypan Blue (Sigma). To examine T cell activation 1 × 10 6 cells per sample were stained with anti-CD4 (RM4.5), anti-CD8 (53-6-7), anti-CD11a (M17/4), anti-CD25 (PC61), anti-CD27 (LG.7F9), anti-CD44 (1M7), anti-CD62L (MEL-14), anti-CD69 (H1-2F3), anti-CD71 (R17217), anti-CXCR3 (CXCR3-173), anti CD45.1 (A20), anti-CD45.2 (104), anti-CD49D (R1-2), anti-PD-1 (RMP1-30), Annexin V and 7-AAD. Intracellular staining for Granzyme B (16G6), anti-CTLA-4 (UC10-4B9) and anti-Ki67 (B56) was performed by permeabilising cells with 0.1% Saponin/PBS. To quantify macrophage/monocyte numbers, 1 × 10 6 cells per sample were stained with anti-F4-80 (BM8), anti-CD11b (M1/70) and anti-CD3 (17A2), to exclude lymphocytes. To assess ex vivo cytokine production, 1 × 10 6 live cells were incubated with PMA (200ng/ml) and ionomycin (1μg/ml) in the presence of Brefeldin A (E-Bioscience) for 5hrs at 37°C 5% CO2. The cells were washed and intracellular staining with anti-mouse IFN-γ (XMG1.2) and anti-mouse TNF (MP6-XT22) was performed as above. All antibodies were obtained from eBioscience or BD-Bioscience. Flow cytometric acquisition was performed using a FACSCalibur or LSR-II (both BD Immunocytometry Systems, USA) and all analysis was performed using Flowjo software (Treestar Inc., OR, USA).
CD4 + and CD8 + T cell isolation
TCRβ + or CD4 + and CD8 + T lymphocytes were positively selected using anti-mouse conjugated midiMACS beads (Miltenyi Biotec) according to the manufacturer's instructions. In some experiments, purified CD4 + and CD8 + T cells were snap frozen in liquid nitrogen and stored at −80°C for real time PCR analysis. In separate experiments, 5-7 ×10 6 purified T cells were adoptively transferred into recipient mice on day 5 after infection with P. berghei ANKA. The purity of positively selected T cell populations was assessed by flow cytometry prior to adoptive transfer or PCR analysis and was typically found to be greater than 90%.
Real Time PCR
RNA isolation from purified CD4 + and CD8 + T cells was performed using RNAeasy isolation kits according to the manufacturer's instructions (Qiagen). Isolated RNA was DNAse treated to remove genomic DNA prior to synthesis of cDNA. cDNA expression for each sample was standardised using the housekeeping genes GAPDH or β-actin. Data are presented as fold change (log 10 ) in gene expression in infected IFN-γ −/− cells/tissues relative to infected WT cells/tissues. Results for each gene were calculated using the formula 2^( Average normalised WT − normalised IFN-γ−/− ). Validated gene expression assays for Tbet, RORγT, GATA-3, IL-4, IL-17, perforin, Bcl-2, BAD, BAX, BIM, CXCl9, CXCL10, RANTES, VCAM-1 and ICAM-1 were purchased from ABI Biosystems (Warrington, UK). PCR Cycling (Taqman, ABI 7500 fast RT-PCR) conditions were: 50 °C for 2 min, 95 °C for 10 min followed by 40 cycles of 15 sec at 95 °C completed with 1 min at 60 °C.
Statistical analysis
Statistical significance was determined using two tailed Student's t test, unless otherwise stated, with P < 0.05 taken as indicating a significant difference.
Results
IFN-γR is heterogeneously expressed on naive and effector T cells in different organs during P. berghei ANKA infection
Consistent with previous studies, WT C57BL/6 mice were exquisitely susceptible to the development of ECM during P. berghei ANKA infection. In contrast, IFN-γ −/− deficient mice were completely resistant to ECM, even though peripheral parasitaemia was comparable in WT and IFN-γ −/− mice throughout the course of infection (Supplementary Figure 1) . To determine whether T cells may be directly controlled by IFN-γ during P. berghei ANKA infection, contributing to the development of ECM, we evaluated the T cellintrinsic expression of the IFN-γR on naive and activated (CD44 + ) CD4 + and CD8 + T cells in WT mice in various tissues during the course of infection. We observed that the frequency of CD4 + and CD8 + T cells expressing the IFN-γR increases during infection in the spleen, lung, liver and brain ( Figure 1 and Supplementary Figure 2) . In naive mice, IFN-γR was expressed predominantly by effector (CD44 + ) CD4 and CD8+ T cells in all organs ( Figure 1 ). In contrast, during malaria infection, IFN-γR was heterogeneously expressed on both naïve and effector CD4 + and CD8 + T cells and the frequency of IFN-γR + cells (and the MFI of IFN-γR expression) varied significantly between the different tissues ( Figure 1 ).
IFN-γ is not required for the activation of splenic CD4 + and CD8 + T cell populations during P. berghei ANKA infection
To investigate whether the T cell response differed between infected WT and IFN-γ −/− mice, we first examined the total numbers of splenic CD4 + and CD8 + T cells during the course of infection: the spleen is believed to be the primary site of immune priming during blood stage malaria infection (reviewed 38). Splenic CD4 + and CD8 + T cell numbers increased at a comparable rate, and plateaued at equivalent levels, in WT and IFN-γ −/− mice suggesting that the initial expansion phase of the T cell response was unimpaired in the absence of IFN-γ ( Figure 2A ). Indeed, splenic T cell proliferation, as measured by the frequencies of cells expressing Ki67, was comparable in WT and IFN-γ −/− mice (results not shown but provided for review). However, the subsequent contraction of splenic CD4 + and CD8 + T cell numbers, between days 5 and 7 post-infection, was markedly attenuated in IFN-γ −/− mice compared to WT mice ( Figure 2A ). Furthermore, in the absence of IFN-γ, expression of the early activation marker CD69 was significantly attenuated on both CD4 + and CD8 + T cells, this was most evident on day 5 post infection, and Granzyme B expression was reduced on day 7 in CD4 + and CD8 + T cells ( 
IFN-γ fine tunes splenic T cell polarisation and effector function during P. berghei ANKA infection
TNF is a potent pro-inflammatory cytokine that is induced by IFN-γ and is associated with severe malarial disease (reviewed 38). Thus, we examined whether TNF production by CD4 + and CD8 + T cells was reduced in IFN-γ −/− mice ( Figure 3) . A large proportion (> 30%) of CD4 + and CD8 + T cells from both naïve WT and naïve IFN-γ −/− mice produced TNF-α after PMA/ionomycin restimulation. TNF responses were maintained throughout the course of infection and were broadly similar in WT and IFN-γ −/− mice; however, on day 5 of infection, the proportion of CD4 + T cells expressing TNF and the mean fluorescence intensity of TNF expression in CD4 + and CD8 + T cells was significantly lower among IFN-γ −/− mice than among WT mice. These data imply that in the absence of IFN-γ, T cells have a slightly reduced capacity to produce TNF-α at a key stage of P. berghei ANKA infection.
As expected, IFN-γ production was completely abrogated in IFN-γ −/− CD4+ and CD8+ T cells whereas CD4 + and CD8 + T cells producing IFN-γ (alone or in combination with TNF) were observed in WT mice throughout the course of infection. Of note, the CD8 + T cells with the highest levels (MFI) of TNF-α production also produced IFN-γ ( Figure 3B ).
Perhaps surprisingly, given that IFN-γ has been shown to be an inhibitor of both Th2 and Th17 lineages (39, 40), we did not detect intracellular IL-17A/F at any time in either CD4 + or CD8 + T cells from either WT or IFN-γ −/− mice (data not shown); we had expected that expression of Th2 and Th17-associated genes would be increased in CD4 + T cells from infected IFN-γ −/− mice. Indeed, expression of GATA3, RORγT and IL-4 mRNA was significantly higher in infection-derived IFN-γ −/− CD4 + T cells than in corresponding WT CD4 + T cells ( Figure 4A, B) . Nevertheless, expression of IL-17A, T-bet and perforin mRNA was similar in WT and IFN-γ −/− CD4 + T cells ( Figure 4A, B) . Similarly, IL-4 mRNA expression was higher in CD8 + T cells from IFN-γ −/− mice compared to WT mice throughout infection, and although T-bet expression was slightly increased in IFN-γ −/− CD8+ T cells isolated on day 7 of infection compared with corresponding WT cells, the expression of IL-17 and perforin did not differ ( Figure 4C ). Thus, in the absence of IFN-γ, there are subtle effects on polarisation of -and cytokine production by -splenic CD4 + and CD8 + T cells during P. berghei ANKA infection but there is no large-scale change in T cell phenotype that might explain the complete resistance to ECM among IFN-γ −/− mice.
IFN-γ regulates tissue-specific accumulation of T cells during P. berghei ANKA infection
We hypothesised that migration to peripheral tissues (rather than cell death) was the cause of reduced splenic T cell numbers in WT mice on day 7 of P. berghei ANKA infection and thus that splenic T cell numbers might be maintained in IFN-γ −/− mice due to their reduced migration. To test this, we enumerated CD4 + and CD8 + T cells in brain, lung and liver of infected WT and IFN-γ −/− mice. Consistent with previous studies (4), CD8 + T cell numbers were significantly higher in the brains of WT mice than those of IFN-γ −/− mice on day 7 post-infection ( Figure 5A ), however the difference in total brain T cell numbers (approx. 5,000 CD8 + T cells per brain) was insufficient to account for the marked loss of T cells in the spleen in WT mice ( Figure 2B ). Moreover, similar (or even higher) numbers of CD4 + and CD8 + T cells were observed in the livers and lungs of IFN-γ −/− mice than in WT mice on day 7 pi (Figure 5B, C). Thus, although T cell migration does differ between WT and IFN-γ −/− mice during P. berghei ANKA infection, it is unlikely that the loss of splenic T cells in WT mice is simply due to enhanced T cell migration to peripheral tissues.
To determine whether altered T cell migration and tissue accumulation in IFN-γ −/− mice was due to cell-intrinsic differences in chemokine receptor expression, we compared T cell expression of CXCR3 and CCR5 (which have been shown to promote T cell migration during P. berghei ANKA infection; 7, 11-13) in WT and IFN-γ −/− mice. Although alterations in chemokine and chemokine receptor expression have been reported in P. berghei ANKA-infected IFN-γ(R) −/− mice (4, 7), T cell-specific CXCR3 and CCR5 expression has not been reported. We observed that CXCR3 is constitutively expressed on hepatic CD4 + T cells and its expression is not affected by P. berghei ANKA infection ( Figure 5D ) and that CCR5 is upregulated to a similar extent on WT and IFN-γ −/− hepatic CD4 + T cells during infection. CXCR3 and CCR5 are both upregulated by infection on CD4 + T cells in the spleen, brain and lung, but this upregulation is significantly attenuated in IFN-γ −/− mice compared to WT mice ( Figure 5D , E). In contrast, CXCR3 expression on CD8 + T cells was upregulated to the same extent in WT or IFN-γ −/− mice (in all organs) during infection ( Figure 5F ). Similarly, CCR5 expression was comparable on CD8 + T cells in WT and IFN-γ −/− mice within the spleen, lung and liver; expression was, however, reduced in CD8 + T cells within the brain of IFN-γ −/− mice ( Figure 5G ). These data suggest that differences in CD8 + T cell migration in IFN-γ −/− mice are more likely to be due to differences in chemokine production within individual tissues than to differences in chemokine receptor expression on T cells. In support of this conclusion, we observed significantly reduced expression of CXCL9 (MIG) and CXCL10 (IP-10) in the brains of IFN-γ −/− mice compared with WT mice on day 7 of infection (Supplementary Figure 4) .
IFN-γ controls the activation of CD4 + T cells but not CD8 + T cells within peripheral tissues during P. berghei ANKA infection
Although similar levels of splenic T cell activation were observed in infected WT and IFN-γ −/− mice, it remained possible that the activation status of T cells migrating to, and accumulating in, the tissues may differ between WT and IFN-γ −/− mice. Importantly, upregulation of IFNγR expression in peripheral non-lymphoid tissues in infected WT mice (Figure 1 ), suggested that IFN-γ may be particularly important in controlling T cell effector Figure 3) . These results indicate that defective CD4 + T cell activation within the brain of IFN-γ −/− mice is unlikely due to increased CTLA-4 and PD-1 mediated suppression.
IFN-γ limits splenic T cell numbers during P. berghei ANKA infection by promoting apoptosis
Since the loss of splenic T cells in P. berghei ANKA-infected WT mice does not seem to be due to increased migration of T cells to peripheral tissues, and since IFN-γ is known to control the contraction phase of the effector response by directing T cell apoptosis (26-33), we compared the frequencies of late stage apoptotic/dead T cells, determined by co-staining with 7-AAD and AnnexinV, in spleens of WT and IFN-γ −/− mice. We observed no significant differences in apoptotic T cell frequencies between uninfected WT and IFN-γ −/− mice, indicating that survival of resting T cells is unaffected by presence or absence of IFN-γ ( Figure 7A-C) . The frequency of apoptotic CD4 + T cells increased significantly in WT mice, but not IFN-γ −/− mice, during P. berghei ANKA infection ( Figure 7A, B) . Similarly, significantly increased frequencies of late stage apoptotic CD8 + T cells were observed in infected WT mice compared with infected IFN-γ −/− mice and uninfected mice, although the frequencies of late stage apoptotic CD8 + T cells was increased in infected IFN-γ −/− mice compared with uninfected controls (Figure 7A , C).
To determine whether reduced T cell apoptosis in IFN-γ −/− mice was due to modulation of the intrinsic pathway of apoptosis we examined, by real-time PCR, the expression of the anti-apoptotic regulator Bcl-2 and the pro-apoptotic molecules BAD, BAX and BIM ( Figure  7 D, E) in purified populations of CD4 + and CD8 + T cells. When compared to cells from WT mice, on day 5 of infection expression of Bcl-2 was increased in CD4 + and CD8 + T cells from IFN-γ −/− mice, suggesting that upregulation of Bcl-2 protects these cells from apoptosis. Levels of BAD and BAX expression were similar in WT and IFN-γ −/− CD4 + and CD8 + T cells throughout the course of infection ( Figure 7D, E) . Surprisingly, however, expression of BIM was increased in IFN-γ −/− derived CD8 + T cells (but not CD4 + T cells) on days 5 and 7 of infection ( Figure 7E ). Taken together, these data suggest that the loss of splenic effector T cells during the course of P. berghei ANKA infection in WT mice is due to IFN-γ-mediated apoptosis: increased Bcl-2 expression may prevent apoptosis in IFN-γ −/− mice but apoptosis in WT mice is unlikely to proceed solely through the classical intrinsic pathway.
IFN-γ −/− T cells are lost from the spleen at a comparable rate and magnitude to WT T cells when placed in an IFN-γ sufficient environment
Our data suggest that, despite marked differences in their susceptibility to T cell-dependent immunopathology, the splenic effector T cell response is broadly similar in P. berghei ANKA infected WT and IFN-γ −/− mice with the only substantial difference being the increased resistance to apoptosis of T cells from IFN-γ −/− mice. To determine whether T cells maturing in the absence of IFN-γ are intrinsically resistant to apoptosis, or whether their resistance is simply due to the lack of circulating IFN-γ, we purified CD4 + and CD8 + T cells from WT and IFN-γ −/− mice on day 5 of P. berghei ANKA infection, transferred them into congenic (CD45.1 + ), infected (day 5; i.e. at the peak of T cell expansion and prior to onset of apoptosis in WT mice) or uninfected, WT mice and determined their recovery 2 days later (i.e. day 7 of infection; peak of apoptosis in WT mice) (Figure 8 ). Representative dot plots showing the recovery of host (CD45.2 − ) and donor (CD45.2 + ) CD4 + T cells in the spleen are shown in Figure 8A . As expected, significantly fewer donor CD4 + T and CD8 + T cells were recovered from spleens of infected recipient mice than from spleens of uninfected recipient mice ( Figure 8B,C) . This was associated with increased recovery of donor cells from the lungs in infected mice ( Figure 8D , E), indicating preferential migration of donor T cells to peripheral tissues rather than the spleen during P. berghei ANKA infection.
However, the increased accumulation of donor cells in non-lymphoid tissues in infected recipients was insufficient to account for the reduced recovery of donor cells in the spleen, strongly suggesting that apoptosis rather than cellular migration controlled donor cell recovery from the spleen. Importantly, CD4 + T cells from IFN-γ −/− mice disappeared at the same rate as CD4 + T cells from WT mice once transferred into an IFN-γ replete host. On the other hand, CD8 + T cells from IFN-γ −/− donors survived better in both infected and uninfected recipients, than did CD8 + T cells from WT donors ( Figure 8C ). Together, these data further indicate that effector CD4 + T cells from WT and IFN-γ −/− mice are not intrinsically different and behave equivalently when placed in comparable (i.e. IFN-γ replete) environments. Although IFN-γ −/− splenic CD8 + T cells seem slightly more resilient than WT CD8 + T cells, they still succumb to IFN-γ-dependent signals during infection.
Contraction of the splenic T cell response in WT mice is an active process mediated on or after day 5 of infection
Our data strongly suggest that differences in maintenance of splenic T cell populations in P. berghei ANKA-infected WT and IFN-γ −/− mice are due to differences in an active process of cell survival and/or apoptosis beginning on or after day 5 of infection and mediated by extrinsic (environmental) signals. To test this hypothesis, we purified splenic CD4 + and CD8 + T cells from WT C57/BL6 CD45.1 + congenic mice on day 5 of P. berghei ANKA infection and adoptively transferred them into infected (day 5 of P. berghei ANKA infection) and uninfected, WT and IFN-γ −/− , CD45.2 + mice. The survival of CD45.1 + donor cells in spleen, lung and brain of infected and uninfected recipient mice was assessed two days after transfer, at the stage when WT mice developed ECM ( Figure 9 ). Representative dot plots showing the recovery of donor (CD45.1 + ) and host (CD45.1 − ) CD4 + T cells from the spleen are shown in Figure 9A . In clear support of the hypothesis, more donor CD4 + and CD8 + T cells were recovered from spleens of infected IFN-γ −/− mice than from those of WT mice ( Figure 9B, C) ; indeed, donor cell numbers in spleens of infected IFN-γ −/− mice were comparable to those in uninfected mice. Since identical cells were transferred into infected WT and IFN-γ −/− hosts, it is evident that loss of splenic T cells in WT mice is an active process, mediated by extrinsic IFN-γ after day 5 of infection. Importantly, the lower recovery of donor T cells from spleens of WT infected mice was not due to increased T cell migration to peripheral tissues as no donor cells were recovered from the brain (data not shown) and equivalent numbers of donor CD4 + and CD8 + T cells were found in the lungs of infected WT and IFN-γ −/− recipients ( Figure 9D, E) . Thus active, non-autocrine IFN-γ-dependent signals control splenic CD4 + and CD8 + T cell survival during P. berghei ANKA infection.
Discussion
We have performed a detailed comparison of the effector T cell response in WT and IFN-γ −/− mice infected with P. berghei ANKA to examine the extent to which cell-intrinsic differences in T cell function determine the resistance of IFN-γ −/− mice to ECM. We have found that CD8 + T cell activation, which is an essential precursor of ECM development (reviewed 14), occurs entirely independently of IFN-γ signaling. However, lack of IFN-γ significantly reduced cerebral migration, or accumulation, of CD8 + T cells; instead, in the absence of IFN-γ, CD8 + T cells accumulated in other organs (such as the lung). Impaired accumulation of CD8 + T cells within the brain of IFN-γ −/− mice was not due to attenuated in situ local proliferation. Although it has previously been suggested that IFN-γ upregulates CCR5-and CXCR3-dependent CD8 + T cell migration pathways during malaria infection (4, 7), we have found that CXCR3 and CCR5 expression by CD8 + T cells is unaffected (spleen, lung) or only marginally affected (brain) by lack of IFN-γ. Thus, our results suggest that CXCR3-and CCR5-dependent CD8 + T cell migration to the lung and brain during P. berghei ANKA infection is unlikely to be controlled primarily at the level of chemokine receptor expression and is more likely dependent on the level of chemokine production within a particular tissue. If so, then IFN-γ may be an important inducer of chemokine expression in the brain, a supposition that is well supported by our data, which is consistent with published results ( In addition to its effects on T cell activation and migration, IFN-γ also regulates T cell survival in the spleen during P. berghei ANKA infection. The contraction phase of the effector T cell response was markedly attenuated in IFN-γ −/− mice, such that by day 7 of infection spleens of IFN-γ −/− mice contained two to three fold more T cells than did spleens of WT mice. Nonetheless, as peripheral parasitaemia was similar in WT and IFN-γ −/− mice, this stronger T cell response does not seem to translate into better parasite control and thus the resistance to ECM of IFN-γ −/− mice cannot be simply be due to lower parasite burdens (as seems to be the case in IP-10 −/− mice; 43). Thus, we postulate that IFN-γ −/− mice are resistant to ECM due to lessened inflammation within the brain and resultant reduced local tissue-parasite accumulation and vascular haemorrhage. In support of this, brain parasite biomass is, known to be lower in IFN-γ −/− mice (16, 17) . Our data suggest that IFN-γ promotes contraction of the effector T cell pool by inducing apoptosis, confirming earlier reports that IFN-γ induces apoptosis of malaria-specific CD4 + T cells (31) . Nevertheless, we have extended the analysis of the role played by IFN-γ to demonstrate that IFN-γ −/− T cells are fully susceptible to apoptosis when transferred into an IFN-γ sufficient environment, and that WT CD4 + T cells are resistant to apoptosis when transferred to an IFN-γ deficient environment. In other words, extrinsic IFN-γ-signalling mediates apoptosis of T cells in infected mice, irrespective of whether the T cell itself can secrete IFN-γ or not. This suggests that apoptosis results from paracrine signalling (e.g. from one T cell to another) rather than autocrine signalling. Moreover, our data suggest that IFN-γ-mediated T cell loss is unlikely to occur solely via the classical intrinsic pathway of apoptosis since T cell expression of the pro-apoptotic molecules BIM, BAD and BAX did not differ significantly between WT and IFN-γ −/− mice. One possibility is that IFN-γ upregulates TNF production and, consequently, that apoptosis is indirectly induced in WT mice by increased death receptor signalling (Trail, TNFR1, DR4/5). Importantly, as the expression of CTLA-4 and PD-1 on splenic CD4 + and CD8 + T cells was unaltered in IFN-γ −/− mice during infection, it is unlikely that these pathways play a large role in regulating the survival and contraction phases of the splenic T cell response during P. berghei ANKA infection.
Moreover, attenuated expression of CTLA-4 and PD-1 by tissue-accumulating CD4 + T cells did not enhance their accumulation within non-lymphoid tissues in IFN-γ −/− mice, also suggesting that cell-intrinsic expression of these co-stimulatory molecules does not significantly regulate CD4 + T cell migration into non-lymphoid tissues during P. berghei 
